Canada markets closed

Grifols, S.A. (GIFLF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
9.650.00 (0.00%)
At close: 09:32AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close9.65
Open10.59
Bid10.35 x 41800
Ask11.18 x 43500
Day's Range9.65 - 10.68
52 Week Range7.46 - 15.80
Volume142
Avg. Volume437
Market Cap6.273B
Beta (5Y Monthly)0.67
PE Ratio (TTM)96.50
EPS (TTM)0.10
Earnings DateMay 14, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJun 03, 2021
1y Target EstN/A
  • Simply Wall St.

    Three Stocks Estimated To Be Trading With Intrinsic Discounts Between 35.9% And 49.7%

    As global markets exhibit mixed signals with the S&P 500 reaching record highs amid cooling labor markets and easing inflation pressures, investors are navigating a complex landscape. In such an environment, identifying stocks that are trading below their intrinsic value could present opportunities for discerning investors looking to potentially enhance their portfolios.

  • Bloomberg

    Grifols Says Founding Family, Brookfield Weigh Takeover Bid

    (Bloomberg) -- Grifols SA said that its founding family and asset manager Brookfield have made an approach to buy and delist it, after the pharmaceutical producer lost billions in market value amid a short-seller attack. The shares jumped the most in four months.Most Read from BloombergMicrosoft Orders China Staff to Use iPhones for Work and Drop AndroidBoeing to Plead Guilty to Fraud for Violating Deal Over 737 Max CrashesBiden Narrows Gap With Trump in Swing States Despite Debate LossMorgan St

  • Reuters

    Grifols says founding family, Brookfield looking to delist drugmaker

    The Grifols family and Canadian fund Brookfield have agreed to evaluate a possible joint takeover bid for beleaguered Spanish drugmaker Grifols with the intent to delist it, the companies said in regulatory filings on Monday. Grifols said its board held an extraordinary meeting over the weekend to study a preliminary offer presented by Brookfield and the Grifols founding family, which holds a stake of around 30%, according to the latest data by Spanish securities regulator CNMV. Brookfield and the family have asked the board for access to certain company information for due diligence before potentially buying all of Grifols' shares, Brookfield and Grifols said in the filings.